We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Companies will partner to advance small molecules in up to six discrete projects, including three existing programs against specific predetermined targets
US-based biotechnology company Exelixis has signed an exclusive collaboration, option and license agreement with India-based Aurigene Discovery Technologies for discovery and development of new oncology treatments.